Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 19.

Niederer, F; Trenkmann, M; Ospelt, C; Karouzakis, E; Neidhart, M; Stanczyk, J; Kolling, C; Gay, R E; Detmar, M; Gay, S; Jüngel, A; Kyburz, D (2012). Downregulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis and Rheumatism, 64(6):1771-1779.

Duroux-Richard, I; Presumey, J; Courties, G; Gay, S; Gordeladze, J; Jorgensen, C; Kyburz, D; Apparailly, F (2011). MicroRNAs as new player in rheumatoid arthritis. Joint, Bone, Spine, 78(1):17-22.

Bombardieri, M; Kam, N W; Brentano, F; Choi, K; Filer, A; Kyburz, D; McInnes, I B; Gay, S; Buckley, C; Pitzalis, C (2011). A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Annals of the Rheumatic Diseases, 70(10):1857-1865.

Stanczyk, J; Ospelt, C; Karouzakis, E; Filer, A; Raza, K; Kolling, C; Gay, R; Buckley, C D; Tak, P P; Gay, S; Kyburz, D (2011). Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis and Rheumatism, 63(2):373-381.

Niederer, F; Ospelt, C; Brentano, F; Hottiger, M O; Gay, R E; Gay, S; Detmar, M; Kyburz, D (2011). SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Annals of the Rheumatic Diseases, 70(10):1866-1873.

Kyburz, D; Gabay, C; Michel, B A; Finckh, A (2011). The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology, 50(6):1106-1110.

Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C (2010). Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent? Annals of the Rheumatic Diseases, 69(2):387-393.

Strobel, K; Fischer, D R; Tamborrini, G; Kyburz, D; Stumpe, K D M; Hesselmann, R G X; Johayem, A; von Schulthess, G K; Michel, B A; Ciurea, A (2010). 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. European Journal of Nuclear Medicine and Molecular Imaging, 37(9):1760-1765.

Finckh, A; Dudler, J; Wermelinger, F; Ciurea, A; Kyburz, D; Gabay, C; Bas, S (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint, Bone, Spine, 77(4):313-318.

Dudler, J; Finckh, A; Kyburz, D; Langenegger, T; Möller, B; Schmiedel, U; Walker, U A (2010). Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis. Swiss Medical Weekly, (140):w13073.

Pierer, M; Schulz, A; Rossol, M; Kendzia, E; Kyburz, D; Haentzschel, H; Baerwald, C; Wagner, U (2009). Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model. Journal of Immunology, 182(5):3139-3145.

Brentano, F; Ospelt, C; Stanczyk, J; Gay, R E; Gay, S; Kyburz, D (2009). Abundant expression of the IL-23 subunit p19, but low levels of bioactive IL-23 in the rheumatoid synovium. Annals of the Rheumatic Diseases, 68(1):143-150.

Brentano, F; Kyburz, D; Gay, S (2009). Toll-like receptors and rheumatoid arthritis. In: O'Neill, L A J; McCoy, C E. Toll-Like Receptors. Heidelberg / New York: Humana Press, 329-343.

Roelofs, M F; Wenink, M H; Brentano, F; Abdollahi-Roodsaz, S; Oppers-Walgreen, B; Barrera, P; van Riel, P L C M; Joosten, L A B; Kyburz, D; van den Berg, W B; Radstake, T R D J (2009). Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Annals of the Rheumatic Diseases, 68(9):1486-1493.

Stanczyk, J; Pedrioli, D M L; Brentano, F; Sanchez-Pernaute, O; Kolling, C; Gay, R E; Detmar, M; Gay, S; Kyburz, D (2008). Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis and Rheumatism, 58(4):1001-1009.

Ospelt, C; Brentano, F; Rengel, Y; Stanczyk, J; Kolling, C; Tak, P P; Gay, S; Gay, R E; Kyburz, D (2008). Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis and Rheumatism, 58(12):3684-3692.

Brentano, F; Schorr, O; Ospelt, C; Stanczyk, J; Gay, R E; Gay, S; Kyburz, D (2007). Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis and Rheumatism, 56(9):2829-2839.

Finckh, A; Ciurea, A; Brulhart, L; Kyburz, D; Möller, B; Dehler, S; Revaz, S; Dudler, J; Gabay, C (2007). B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis and Rheumatism, 56(5):1417-1723.

Distler, M; Distler, J; Ciurea, A; Kyburz, D; Müller-Ladner, U; Reich, K; Distler, O (2006). Evidenzbasierte Therapie des Raynaud-Syndroms. Zeitschrift für Rheumatologie, 65(4):285-289.

This list was generated on Sat Feb 16 06:41:53 2019 CET.